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Abstract
The thesis entitled "Studies Towards the Synthesis of Laulimalide and Synthesis of Chiral Tetrahydrofurans of Therapeutic Value" is divided into three chapters. 
Chapter I: Stereoselective Synthesis of C3-C10 and C13-C21 Fragments of 'Laulimalide' from L-Ascorbic Acid This chapter is dealt with the synthesis of C3-C10 (5) and C13-C21 (3) segments of antitumor macrolide 'laulimalide'. Marine natural products containing macrocyclic features have been shown to exhibit anticancer properties with significant clinical potential. 1 One such compound is laulimalide (1) ('laulima' means 'work together' against cancer). In the development of novel antitumor drugs, recent attention has been focused on microtubule-stabilizing agents, the most popular ones being paclitaxel (Taxol)2 and the epothilones.3 More recently several other antitumor agents showing a similar mode of action have been identified, among which laulimalide is distinguished by a particularly high 'multi drug resistance' (MDR).4 
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Laulimalide, also known as figianolide B is a 20-membered macrolide isolated from the Indonesian sponge Hyattella sp.5 More recently laulimalide has also been isolated from an Okinawan sponge Fasciospongia rimosa.6 It has exhibited potent cytotoxicity in the range of 10-50 ng/mL (IC50 values) against numerous human cancer cell lines.7 The remarkable antitumor activities as well as the unique structural features have prompted considerable interest in the synthesis of laulimalide. 
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Here in, we synthesised the C3-C10 and C13-C21 segments (Scheme 1) of microtubule-stabilizing agent (-)-laulimalide. C3-C10 segment 5 could be the late stage intermediate of 2. According to the retrosynthetic analysis, 2,3-O-isopropylidene-L-glyceraldehyde 10 and PMB protected homopropargyl alcohol 13 and (2S,3S)-1,2-O-isopropylidene-3,4-epoxybutanediol 17 and PMB protected propargyl alcohol 16 were found to be starting materials for C3-C10 and C13-C21 segments respectively (Scheme 2). Compounds 10 and 17 could be prepared from L-ascorbic acid. C3-C10 segment is prepared by convergent synthetic method whereas C13-C21 segment is prepared by linear synthetic method. Accordingly, to synthesise C3-C10 segment 5, 2,3-O-isopropylidene-(2S)-glyceraldehyde 10 was treated with (carbethoxymethylene)triphenyl phosphorane in MeOH to give 188 (Scheme 3), followed by catalytic hydrogenation in the presence of PtO2 (catalytic) in EtOAc gave 19, which on reduction with LiAlH4 in dry THF afforded alcohol 20. Further protection of hydroxy group in 20, with MEMCl in THF gave 9, which on acetonide hydrolysis with 60% aq. AcOH afforded diol 21. Tosylation of 21 with p-TsCl in Et3N and CH2Cl2 gave monotritylate 22, which was treated with K2CO3 in MeOH to furnish epoxide 7. Figure (​http:​/​​/​www.csirexplorations.com​/​images_et​/​a60_figureNO3.jpg" \t "_blank​) Figure (​http:​/​​/​www.csirexplorations.com​/​images_et​/​a60_figureNO4.jpg" \t "_blank​) 
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On other hand, PMB protected homopropargyl alcohol 13 was reacted with n-BuLi, parafarmaldehyde in dry THF at -78 ?C to 40 ?C to give 12, which was paRTially reduced with LiAlH4 at room temperature to furnish trans allyl alcohol derivative 23. Sharpless epoxidation9 of 23 with (+)-DIPT, Ti(OPri)4, cumene hydroperoxide in dry CH2Cl2 at -20 ?C for 3 h gave asymmetric epoxy alcohol 11, which was treated with PPh3, catalytic amount of NaHCO3 (cat.) in CCl4 to furnish 24. Chloro derivative 24 was treated with LDA in dry THF at -40 ?C10 for 3 h to give chiral propargyl alcohol derivative 25, which was treated with TBDMSCl in CH2Cl2 in the presence of imidazole to give 8. The coupling reaction of 7 and 8 in the presence of n-BuLi, BF3.OEt2 in dry THF at -78 ?C furnished 26. Treatment of 26 with TBAF in CH2Cl2 gave the diol 27, which was partially hydrogenated in the presence of catalytic Pd-BaSO4 (Lindlar's catalyst), quinoline in hexane11 to give the cis olefinic compound 6. Finally, regioselective tosylation at O-3, followed by base catalysed intramolecular O-7 nucleophilic displacement with inversion at C-3 in diol 6 in the presence of p-TsCl in pyridine12 gave trans cyclised product 5. The structure of 5 as major product along with ditosylate (10%) was unambiguously assigned based on the spectral data. Having successfully synthesised the C3-C10 segment 5, then it was aimed to synthesise the C13-C21 segment 3. Initially, diol 28 was tosylated in the presence of p- TsCl, Et3N in CH2Cl2 to give monotosylate 29 (Scheme 4), which was treated with K2CO3 in MeOH to furnish epoxide 17. On reaction with 16 in the presence of n-BuLi, BF3.OEt2 in dry THF at -78 ?C, epoxide 17 gave 30. Acetonide hydrolysis in 30 in the presence of 60% aq. AcOH at room temperature gave triol 31, which was tritylated with TrCl in the presence of Et3N in CH2Cl2 to give monotritylated compond 32 exclusively. Diol 32 was protected with 2,2-DMP in dry DMSO in the presence of PTSA (cat.) at room temperature for 3 h furnished 15. PMB deprotection of 15 with DDQ in CH2Cl2:H2O (19:1) at room temperature gave propargyl alcohol derivative 33, which was partially reduced to trans allyl alcohol the presence of LiAlH4 in dry THF at 0 ?C to RT for 4 h. The trans allyl alcohol derivative 14 was epoxidised using Sharpless asymmetric epoxidation, in the presence of 
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Reagents and conditions: a) p-TsCl, Et3N, CH2Cl2, RT, 8 h; b) K2CO3, MeOH, RT, 1 h; c) 16, n-BuLi, BF3.OEt2, dry THF, 2 h; d) i. PTSA, MeOH, RT,7 h; ii. TrCl, Et3N, CH2Cl2, RT, 4 h; e) i. 2,2-DMP, dry DMSO, PTSA (cat.)RT, 5 h, ii. DDQ, CH2Cl2:H2O (19:1), RT, 2 h; f) LiAlH4, dry THF, RT, 4 h; g) i. (+)-DIPT, Ti(OPri)4, cumene hydroperoxide, MS 4 ?, CH2Cl2, -20 ?C, 3 h, ii. IBX, dry DMSO, RT, 1 h; h) 2,3-dibromo-1-propene, Zn, sat. aq. NH4Cl soln., THF, 0 ?C to RT, 3 h. 
(+)-DIPT, Ti(OPri)4, cumene hydroperoxide, MS 4 ? in dry CH2Cl2 at -20 ?C for 3 h to give epoxy alcohol 34. Oxidation of 34 with IBX in dry DMSO at room temperature for 1 h gave epoxy aldehyde 35. Zinc (Metal) mediated nucleophilic addion on carbonyl functional group in aqueous medium (saturated aqueous NH4Cl solution) is well studied in the literature, which gives high diastereoselectivity (anti > 90%) corresponding to adjacent chiral centre present to the carbonyl group. The same strategy was successfully utilized to create the required stereochemistry of newly formed hydroxy group at C-15 with good diastereoselectivity as a separable mixture of isomers. Accordingly, 35 reacted with 2,3-dibromo-1-propene in the presence of zinc in THF and sat. aq. NH4Cl solution13 at 0 ?C to RT for 3 h to afford 3 as a separable mixture of diastereomers with good diastereoselectivity. 
Chapter II: Synthesis of Anti-Asthmatic Compounds (2S,5S)-trans, (2R,5S)-cis, (2R,5R)-trans and (2S,5R)-cis-5-(4-fluorophenoxymethyl) -2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofurans This chapter is dealt with the synthesis of (2S,5S)-trans-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran (1), (2R,5S)-cis-5-(4-fluorophenoxy methyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran (2), (2R,5R)-trans-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran (3) and (2S,5R)-cis-5-(4-fluorophenoxy methyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran (4). 2,5-Disubstituted tetrahydrofurans (THF) are structural features commonly encountered in a variety of natural products.14 The preparation of such compounds, because of their importance in many biological processes, has attracted particular attention from organic synthetic chemists. The chiral tetrahydrofurans, (2S,5S)-trans-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran 1 and (2R,5R)-trans-5-(4-fluorophenoxymethyl)- 2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran 3 were well studied for their action against 5-lipoxygenase and compound 1 found to be a potent orally active leukotriene modulator with a very good safety profile. They have been designed to provide both symptomatic relief and therapeutic value to patients with chronic bronchial asthma. Compound 1 is a highly selective, orally active leukotriene modulator that works by inhibiting the action of 5-lipoxygenase (5-LO) to block the generation of cysteinyl leukotrienes and LTB4, both of which are associated with the inflammatory response in the lungs and with the clinical sequllae, including bronchospan.15 Here in, we report the synthesis of 1, 3 and their stereoisomers 2 and 4 starting from (S)- and (R)-2,3-O-isopropylidene glyceraldehydes by a flexible approach. Based on the retrosynthetic analysis as depicted in Scheme 5, 1, 2, 3 and 4 could be prepared from 5, 6, 7 and 8, which in turn could be made from the propargylic alcohol derivatives 9 and 10. The alcohols 9 and 10 would be derived starting from 11 and 12 independently. Wittig olefination reaction of 11 (Scheme 6) with (carbethoxymethylene)triphenyl phosphorane in MeOH gave 13, which on hydrogenation in the presence of catalytic amount of PtO2 (Adam's catalyst) at room temperature furnished 14 in quantitative yield. Ester 14 was subjected to reduction with LiAlH4 in dry THF to give alcohol 15, which on oxidation with IBX in dry DMSO afforded aldehyde 16. Compound 16 on reaction with lithium anion of 1-(4-methoxybenzyloxy)butyne generated from n-BuLi and 16 in dry THF at -78 ?C to room temperature gave 9 as a 1:1 mixture of isomers. Since, 9 was an inseparable mixture of isomers, it was used as such in further reactions. Alcohol 9 was treated with Ac2O and Et3N in CH2Cl2 at room temperature to furnish 17, which on acetonide hydrolysis with 60% aqueous AcOH at room temperature afforded 18. Tosylation of diol 18 using p-TsCl and Et3N in CH2Cl2 gave monotosylate 19, which on treatment with K2CO3 in MeOH at room temperature gave the desired 2,5-disubstituted tetrahydrofuran derivative 20. Compound 20 was subjected to tosylation with p-TsCl and Et3N to give 21, which on further reaction with NaH and p-fluorophenol in DMF at 80 ?C furnished 22. 
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Compound 22 was treated with DDQ in CH2Cl2-H2O (19:1) to afford the corresponding hydroxy compounds 5 and 6, in overall 72% yield as a separable mixture by column chromatography (silica gel, finer than 200 mesh, EtOAc-petroleum ether, 1:5). These two compounds, 5 and 6 were unambiguously characterised from the spectral data. Finally, conversion of these diastereomerically pure compounds 5 and 6 to the targets 1 and 2, since is well studied in the literature,16 (In further, using the two reactions which convert 5 and 6 to 1 and 2 were studied to synthesize 3 and 4 from 7 and 8 respectively), formally the study completes the synthesis of 1 and 2. Synthesis of 3 and 4 was initiated from 2,3-O-isopropylidene-(2R)-glyceraldehyde (12). Thus, Wittig olefination of 12 (Scheme 6) with (carbethoxymethylene)triphenyl phosphorane in MeOH gave 23, which on hydrogenation (using PtO2 as catalyst) followed by reduction of ester 24 with LiAlH4 in THF furnished 25. Oxidation of 25 with IBX in DMSO gave aldehyde 26 in 81% yield. Compound 26 on reaction with lithium anion (generated from 1-(4-methoxybenzyloxy)butyne and n-BuLi) in THF gave 10 as a 1:1 inseparable mixture of isomers, which was used as such for further reaction. 10 on acetylation with Ac2O, Et3N and DMAP (cat.) gave 27. Acetonide hydrolysis in 27 using 60% aq. AcOH gave diol 28, followed by tosylation furnished monotosylate 29, which was cyclised using K2CO3 in MeOH to give 30. 30 was tosylated to give 31, further reaction with NaH, 4-F-C6H4OH in DMF gave 32. PMB deprotection of 32 gave separable mixture of isomers 7 and 8 (silica gel, finer than 200 mesh, EtOAc:petroleum ether, 1:5), whose structures were thoroughly confirmed by spectral data. 7 and 8 were independently subjected to PhOCOONHCOOPh, Ph3P, DIAD in dry THF17 at RT for 1 h to give 33 and 34 respectively. Ammonolysis of 33 and 34 with NH4OH in MeOH gave required final hydroxy urea derivatives 3 and 4 independently. Hence, the synthesis of anti-asthmatic compounds 1, 2, 3 and 4 were successfully achieved by a flexible approach starting from S- and R-glyceraldehyde derivatives. Having successfully synthesised all the four possible stereoisomers of 5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran of therapeutic importance, the strategy was then extended to establish a 'short route' to synthesize all the above four isomers. 
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'Keto-epoxide' cyclisation was found to be a flexible method for the preparation of substituted tetrahydrofurans with required stereochemistry among the known methods. The newly formed stereo centres could be created with required stereochemistry by taking appropriate asymmetric epoxide, using Lewis acid and reducing agents (Scheme 7). This method is based on the participation of the oxygen atom from the carbonyl in the opening of the epoxide with inversion of configuration, followed by reduction of the oxonium ion so formed and then cyclisation. The intra- molecular reduction leads predominantly to the trans isomer, whereas an inter- molecular reduction produces the cis isomer.18 The final stereochemistry of the newly formed centres of substituted tetrahydrofuran depends on the stereochemistry of the epoxide. BH3.Me2S acts as a Lewis acid and a hydride source to give intra- molecular reduction-cyclisation product. Initially our aim was to establish a 'short route' to 35. According to the retrosynthetic analysis (Scheme 8), 35 could be prepared from 36, which intrun could be prepared from racemic keto-epoxide 37. 37 would be made from 4-pentenoic acid 38. 
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Accordingly, 38 was initially converted to mixed anhydride 39 with ethyl chloroformate, Et3N in dry Et2O and was immediately treated with lithium anion (generated from 1-(4-methoxybenzyloxy)butyne and n-BuLi) in THF at -78 ?C to furnish 40. The terminal olefin present in 40 was oxidised using oxone, solid NaHCO3 in acetone:water (1:1) to furnish epoxide 37. The racemic keto-epoxide 37 was treated with BH3-Me2S in dry CH2Cl2 at -78 ?C to give an inseparable mixture of racemic 2,5-disubstituted tetrahydrofurans 36 (36 is comparable with compounds 20 and 30 by TLC, 1H NMR and other spectral data), the conversion of 36 to compound 3516 is reported in the preceding section. Thus, a 'short route' for the synthesis of (2RS,5RS)-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran is successfully established. This route can be exploited to synthesize the diastereomerically pure above compounds epoxidising the terminal olefin using Jacobsen's catalyst to get required stereochemistry and using the Lewis acid appropriately, the required isomer of four isomers can be stereoselectively synthesised in optically pure form. 
Chapter III: Stereoslective Synthesis of Biologically Active Chiral Tetrahydrofurans Section A: Flexible Approach for the Asymmetric Synthesis of (2S,5S)-trans and (2R,5S)-cis-5-(4-Fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofurans The chiral tetrahydrofurans, (2S,5S)-trans-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran (1a) and (2R, 5S)-cis-5-(4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran (2a) were well studied for their action against 5-lipoxygenase (5-LO) and compound 1a was found to be a potent and orally active leukotriene modulator that works by inhibiting the action of 5-lipoxygenase (5-LO) to block the generation of cysteinyl leukotrienes and LTB4, both of which are associated with the inflammatory response in the lung and with the clinical sequllae, including bronchospan. It has been designed to provide both symptomatic relief and therapeutic value to patients with chronic bronchial asthma. 
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The therapeutic importance of chiral tetrahydrofurans 1a and 2a prompted a study for their biological transformations and degradation in in vivo systems and such a study needs side chain isotopically labelled 1a and 2a. Hence, it was planned to synthesise the acetylenes 1 and 2, from which it is easy not only to synthesise the desired side chain labelled 1a and 2a, but also to synthesise a variety of new chemical entities (NCEs) for further biological evaluation. Thus, the present study reports the synthesis of 1a and 2a, by a flexible Sharpless asymmetric epoxidation approach starting from 2,3-O-isopropylidene-(2S)-glyceraldehyde (6). Based on retrosynthetic analysis (Scheme 10), the present study is a combinatio of chiron and asymmetric synthesis approach. Accordingly, 1a and 2a could be envisaged from acetylenes 1 and 2 correspondingly, the acetylenes 1 and 2 could be made from chiral propargyl alcohols 3 and 4 respectively, which inturn could come from 
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allylic alcohol 5. This alcohol 5 could be envisaged from 2,3-O-isopropylidene-(S)-glyceraldehyde 6. Accordingly, the aldehyde 7 (synthesis of 7 is reported in Chapter II) was subjected to Wittig olefination with (carbethoxymethylene)triphenyl phosphorane in benzene at reflux temperature to give 8 (Scheme 11), which on selective ester reduction with DIBAL-H in CH2Cl2 at -20 ? C furnished allylic alcohol 5. The thus prepared allylic alcohol 5 would be utilized in a flexible strategy for the asymmetric synthesis of 1 and 2.Accordingly, Sharpless asymmetric epoxidation9 on 5 (Scheme 11) using (+)-DIPT along with Ti(OPri)4 and cumene hydroperoxide at -20 ?C resulted in the epoxy alcohol 9. Reaction of 9 with Ph3P in CCl4 in the presence NaHCO3 (cat.) at reflux gave 10. The chiral epoxy chloride10 on treatment with LDA10 at -40 ?C furnished the chiral propargyl alcohol 3, which on acetylation with Ac2O, Et3N and DMAP (cat.) in CH2Cl2 furnished the corresponding acetate 11. Compound 11 on reaction with aq. AcOH (60%) at room temperature gave the diol 12, which on monotosylation with p-TsCl and Et3N in CH2Cl2 afforded monotosylate 13 as a major product. Cyclisation of tosylate 13 with K2CO3 in MeOH at room temperature afforded the 2,5-disubstituted tetrahydrofuran 14. Tosylation of 14 on treatment with p-TsCl, Et3N and DMAP (cat.) in CH2Cl2 gave 15, which on further treatment with 4-fluorophenol in the presence of NaH in DMF at 80 ?C afforded 1. Treatment of ethylene oxide with 1 in the presence of n-BuLi, BF3.OEt2 in dry THF at -78 ?C for 2 h gave 16. The reactions, which convert 16 to the required final compound 1a is reported16 in 'Chapter II' for the synthesis of 3 and 4 from 33 and 34 respectively. Similarly, Sharpless epoxidation of allylic alcohol 5 (Scheme 11) with (-)-DIPT gave corresponding epoxy alcohol 17, which was further converted into epoxy chloride 18. Reaction of 18 with LDA in dry THF at -40 ?C for 3 h gave chiral propargyl alcohol derivative 4, which on acetylation gave the acetate 19. Deprotection of acetonide in 19 using 60% aqueous AcOH afforded diol 20, which was subjected to tosylation to give monotosylate 21 as a major product. Treatment of 21 with K2CO3 in MeOH gave 2,5 disubstituted tetrahydrofuran 22, which on tosylation followed by further treatment of tosylate 23 with 4-fluorophenol in the presence of NaH at 80 ?C gave 2. Treatment of ethylene oxide with 2 in the presence of n-BuLi, BF3.OEt2 in dry THF at -78 ?C for 2 h gave 24. The reactions, which convert 24 to the required final compound 2a is reported16 in 'chapter II' to for the synthesis of 3 and 4 from 33 and 34 respectively. 
Section B: Stereoselective Synthesis of (2R,3S,4R,5R)-3,4-Dihydroxy-5- (4-fluorophenoxymethyl)-2-(1-N-hydroxyureidyl-3-butyn-4-yl)tetrahydrofuran 
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Chiral tetrahydrofuran based compounds such as A and several 2,5-disubstituted tetrahydrofuran compounds with biological activity were found in nature. The research for the development of new drugs based on such chiral tetrahydrofurans resulted in several analogues having anti-inflammatory activity. Such a research resulted in a therapeutically interesting tetrahydrofuran A and its stereoisomers as potent 5-lipoxygenase (5-LO) inhibitors. In furthering the research on the development of new chiral furans with potent activity, herein, we report the first stereoselective synthesis of 1, starting from 'D-mannose diacetonide'. From the antithetic analysis (Scheme 12), it was envisaged that 1 could be synthesised from 2, which inturn could be made from 3, 3 could be prepared from 'mannose diacetonide' 4. Accordingly, reaction of lithium anion of 1-(4-methoxybenzyloxy)butyne (Scheme 13) 
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generated in situ on reaction of1-(4-methoxybenzyloxy)butyne and n- BuLi in THF at -78 ?C with 4 gave diol 5. Diol 5 was subjected to cyclisation using Ph3P and DIAD in dry THF to give 3, which was found to be a-anomer as is evident from 1H NMR study. Acetonide deprotection in 3 with conc.HCl (cat.) in MeOH:H2O (9:1) at room temperature for 3 h gave diol 6, which on oxidative cleavage with NaIO4 and aq. NaHCO3 in CH2Cl2 gave aldehyde 7. Reduction of aldehyde 7 with NaBH4 in MeOH furnished alcohol 8. Alcohol 8 was subjected to tosylation using p-TsCl and Et3N in CH2Cl2 in the presence of DMAP (cat.) at room temperature to afford 9, which on reaction with p-fluorophenol and NaH in DMF furnished 2. Deprotection of PMB-protecting group in 2 using DDQ in aqueous CH2Cl2 (1:19) at room temperature afforded 10, which in two steps was converted into the urea derivative. Accordingly, alcohol 10 was treated with N,O-bis(phenyloxycarbonyl)hydroxylamine, Ph3P and DIAD in dry CH2Cl217 to give 11, which on ammonolysis with NH4OH in MeOH gave hydroxy urea derivative 12. Finally deprotection of acetonide in 12 with catalytic quantity of conc. HCl in MeOH at room temperature for 24 h gave 1 in 78% yield, whose structure was unambiguously ascertained from the spectral analysis. Hence, for the first time, 3,4-dihydroxy 2,5 disubstituted tetrahydrofuran derivative 1. 
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Reagents and conditions: a) HC?CCH2CH2OPMB, n-BuLi, -78 ?C to RT, 2 h; b) DEAD, Ph3P, dry THF, RT, 1 h; c) cat. conc. HCl (cat.), MeOH:H2O (9:1), 0 ?C to RT, 3 h; d) i. NaIO4, sat. aq. NaHCO3 soln., CH2Cl2, RT, 5 h; ii. NaBH4, MeOH, RT, 1 h; iii. p-TsCl, Et3N, DMAP (cat.), CH2Cl2, 0 ?C, 12 h; iv. 4-F-C6H4OH, NaH, DMF, 80 ?C, 4 h; e) i. DDQ, CH2Cl2:H2O (19:1), RT, 4 h; ii. DIAD, Ph3P, PhOCONHOCOOPh, dry CH2Cl2, RT, 2 h; iii. NH4OH, MeOH, rt, 3 h; f) conc. HCl (cat.), MeOH, 24 h. 


